Literature DB >> 16160582

Outcomes and complications after heart transplantation: a review.

Frances M Hoffman1.   

Abstract

In more than 35 years of experience with heart transplantation, improvements in patient selection, surgical techniques, organ preservation, and postoperative management have increased survival rates and reduced complications. However, a number of significant complications continue, limiting the benefit of heart transplantation as the long-term solution for patients. Current survival rates are 83% at 1 year and 72% at 5 years, with 50% of patients surviving 9.4 years or more. Recipient and donor characteristics influence survival outcome. Primary graft dysfunction is the most frequent cause of death during the first 30 days. The function of the transplanted heart allows return to pre-illness activities, though denervation limits peak exercise capacity. Advances in immunosuppressive medications have decreased the incidence and severity of rejection, though only recently have shown promise in attenuating the incidence of cardiac graft vasculopathy, the major complication limiting long-term graft function. This review addresses current outcomes and the short- and long-term complications of heart transplantation.

Entities:  

Mesh:

Year:  2005        PMID: 16160582     DOI: 10.1097/00005082-200509001-00005

Source DB:  PubMed          Journal:  J Cardiovasc Nurs        ISSN: 0889-4655            Impact factor:   2.083


  2 in total

1.  Effects of the left ventricular assist device on the compliance and distensibility of the carotid artery.

Authors:  Danielle L Templeton; Ranjit John; Patricia Painter; Aaron S Kelly; Donald R Dengel
Journal:  Heart Vessels       Date:  2012-08-09       Impact factor: 2.037

2.  Monitoring pharmacologically induced immunosuppression by immune repertoire sequencing to detect acute allograft rejection in heart transplant patients: a proof-of-concept diagnostic accuracy study.

Authors:  Christopher Vollmers; Iwijn De Vlaminck; Hannah A Valantine; Lolita Penland; Helen Luikart; Calvin Strehl; Garrett Cohen; Kiran K Khush; Stephen R Quake
Journal:  PLoS Med       Date:  2015-10-14       Impact factor: 11.069

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.